Tags

Type your tag names separated by a space and hit enter

Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.
Virus Res. 2020 09; 286:198057.VR

Abstract

The fight against the novel coronavirus pneumonia (namely COVID-19) that seriously harms human health is a common task for all mankind. Currently, development of drugs against the novel coronavirus (namely SARS-CoV-2) is quite urgent. Chinese medical workers and scientific researchers have found some drugs to play potential therapeutic effects on COVID-19 at the cellular level or in preliminary clinical trials. However, more fundamental studies and large sample clinical trials need to be done to ensure the efficacy and safety of these drugs. The adoption of these drugs without further testing must be careful. The relevant articles, news, and government reports published on the official and Preprint websites, PubMed and China National Knowledge Infrastructure (CNKI) databases from December 2019 to April 2020 were searched and manually filtered. The general pharmacological characteristics, indications, adverse reactions, general usage, and especially current status of the treatment of COVID-19 of those potentially effective drugs, including chemical drugs, traditional Chinese medicines (TCMs), and biological products in China were summarized in this review to guide reasonable medication and the development of specific drugs for the treatment of COVID-19.

Authors+Show Affiliations

School of Public Health and School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.The Third People's Hospital of Chengdu, Chengdu, 610031, China.School of Public Health and School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.School of Public Health and School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.School of Public Health and School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. Electronic address: pengchengchengdu@126.com.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

32531236

Citation

Pan, Xiaoqi, et al. "Potential Drugs for the Treatment of the Novel Coronavirus Pneumonia (COVID-19) in China." Virus Research, vol. 286, 2020, p. 198057.
Pan X, Dong L, Yang L, et al. Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China. Virus Res. 2020;286:198057.
Pan, X., Dong, L., Yang, L., Chen, D., & Peng, C. (2020). Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China. Virus Research, 286, 198057. https://doi.org/10.1016/j.virusres.2020.198057
Pan X, et al. Potential Drugs for the Treatment of the Novel Coronavirus Pneumonia (COVID-19) in China. Virus Res. 2020;286:198057. PubMed PMID: 32531236.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China. AU - Pan,Xiaoqi, AU - Dong,Lan, AU - Yang,Lian, AU - Chen,Dayi, AU - Peng,Cheng, Y1 - 2020/06/09/ PY - 2020/03/20/received PY - 2020/05/15/revised PY - 2020/06/07/accepted PY - 2020/6/13/pubmed PY - 2020/9/9/medline PY - 2020/6/13/entrez KW - Biological products KW - COVID-19 KW - Chemical drugs KW - SARS-CoV-2 KW - Traditional Chinese medicines SP - 198057 EP - 198057 JF - Virus research JO - Virus Res VL - 286 N2 - The fight against the novel coronavirus pneumonia (namely COVID-19) that seriously harms human health is a common task for all mankind. Currently, development of drugs against the novel coronavirus (namely SARS-CoV-2) is quite urgent. Chinese medical workers and scientific researchers have found some drugs to play potential therapeutic effects on COVID-19 at the cellular level or in preliminary clinical trials. However, more fundamental studies and large sample clinical trials need to be done to ensure the efficacy and safety of these drugs. The adoption of these drugs without further testing must be careful. The relevant articles, news, and government reports published on the official and Preprint websites, PubMed and China National Knowledge Infrastructure (CNKI) databases from December 2019 to April 2020 were searched and manually filtered. The general pharmacological characteristics, indications, adverse reactions, general usage, and especially current status of the treatment of COVID-19 of those potentially effective drugs, including chemical drugs, traditional Chinese medicines (TCMs), and biological products in China were summarized in this review to guide reasonable medication and the development of specific drugs for the treatment of COVID-19. SN - 1872-7492 UR - https://www.unboundmedicine.com/medline/citation/32531236/Potential_drugs_for_the_treatment_of_the_novel_coronavirus_pneumonia__COVID_19__in_China_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0168-1702(20)30250-1 DB - PRIME DP - Unbound Medicine ER -